January 4, 2018 / 5:48 PM / in 9 months

BRIEF-Auris Medical Announces Further Results From Healos Phase 3 Trial

Jan 4 (Reuters) - Auris Medical Holding Ag:

* AURIS MEDICAL HOLDING AG SAYS ANNOUNCED FURTHER CLINICAL RESULTS FROM THE HEALOS PHASE 3 CLINICAL TRIAL, PROVIDES UPDATE ON AM-111 DEVELOPMENT PROGRAM

* AURIS MEDICAL HOLDING AG SAYS AM-111 TREATED PATIENTS HAD A LOWER INCIDENCE OF NO HEARING IMPROVEMENT- SEC FILING

* AURIS MEDICAL HOLDING SAYS POST-HOC ANALYSES OF TOP-LINE DATA REVEALED CLINICALLY AND STATISTICALLY SIGNIFICANT HEARING IMPROVEMENT WITH AM-111

* AURIS MEDICAL HOLDING SAYS PLANS TO DISCUSS ACCUMULATED SAFETY AND EFFICACY DATA AND REGULATORY PATHWAY WITH FDA AND EMA IN Q2 OF 2018. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below